Shasun puts loss from closure of Cuddalore plant at Rs 50 crore

25 Mar 2011 Evaluate

Shasun Pharmaceuticals estimates a loss of Rs 50 crore from the closure of its Cuddalore plant due to a chemical leak two weeks ago. The plant which makes anti-ulcerant drugs such as Ranitidine, Nizatidine and Gabapentin, expects to start operations in a day or two.

The drug maker reported a profit of Rs 37 lakh on flat revenue of Rs 145 crore for the third quarter ending December 31, 2010. For the preceding quarter ending September 30, 2010, Shasun reported a loss of Rs 5.5 crore on a turnover of Rs 147 crore.crackcrack

Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×